Burger P C, Minn A Y, Smith J S, Borell T J, Jedlicka A E, Huntley B K, Goldthwaite P T, Jenkins R B, Feuerstein B G
The Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
Mod Pathol. 2001 Sep;14(9):842-53. doi: 10.1038/modpathol.3880400.
Comparative genomic hybridization (CGH), fluorescence in situ hybridization (FISH), polymerase chain reaction-based microsatellite analysis, and p53 sequencing were performed in paraffin-embedded material from 18 oligodendrogliomas and histologically similar astrocytomas. The study was undertaken because of evidence that concurrent loss of both the 1p and 19q chromosome arms is a specific marker for oligodendrogliomas. Of the six lesions with a review diagnosis of oligodendroglioma, all had the predicted loss of 1p and 19q seen by CGH, FISH, and polymerase chain reaction. Other lesions, including some considered oligodendroglioma or mixed glioma by the submitting institution, did not. There were no p53 mutations in any of the six oligodendrogliomas, whereas 5 of the 10 remaining, successfully studied cases did have p53 mutations. The results suggest that CGH and FISH performed on current or archival tissue can aid in classification of infiltrating gliomas such as oligodendrogliomas and astrocytomas. The results of the p53 studies are consistent with findings of previous investigations that such mutations are less common in oligodendrogliomas than they are in astrocytomas.
对18例少突胶质细胞瘤及组织学上类似的星形细胞瘤的石蜡包埋材料进行了比较基因组杂交(CGH)、荧光原位杂交(FISH)、基于聚合酶链反应的微卫星分析和p53测序。开展该研究是因为有证据表明1号染色体短臂(1p)和19号染色体长臂(19q)同时缺失是少突胶质细胞瘤的一个特异性标志物。在6例经复查诊断为少突胶质细胞瘤的病变中,所有病例通过CGH、FISH和聚合酶链反应均呈现出预期的1p和19q缺失。而其他病变,包括提交机构认为是少突胶质细胞瘤或混合性胶质瘤的一些病例,则未出现这种情况。6例少突胶质细胞瘤中均未发现p53突变,而在其余10例成功研究的病例中,有5例存在p53突变。结果表明,对当前或存档组织进行CGH和FISH有助于对浸润性胶质瘤如少突胶质细胞瘤和星形细胞瘤进行分类。p53研究结果与先前调查结果一致,即此类突变在少突胶质细胞瘤中比在星形细胞瘤中更少见。